With pharmaceutical products taking years and millions of dollars to develop, companies have to be sure that the market is sufficiently attractive and that they understand key market dynamics well in advance.
Forecasting teams, market research departments and brand managers turn to IMS for innovative forecasting solutions, market opportunity assessments and reimbursement and market access guidance. For more than 25 years, our team of highly qualified forecasting experts has leveraged deep information and analytics to provide accurate, robust, evidence-based forecasts.
In addition to our customized forecasting insights from the IMS Consulting Group, we offer syndicated easy-to-use tools such as Market Prognosis, Therapy Forecaster, Analogue Planner and New Product Spectra. Our insights help you understand a product’s likelihood of success — from awareness, trial and usage to product volume and prescribing dynamics.
Because we’re continually evaluating new markets and licensing candidates, we help clients take the guesswork out of product planning.
IMS Healthcare Institute leader Murray Aitken talks about expected market dynamics and sources of growth.